- Home
- TOPP vs ANTX Comparison
TOPP vs ANTX Comparison
Compare TOPP & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- ANTX
- Stock Information
- Founded
- TOPP 2014
- ANTX 2017
- Country
- TOPP United States
- ANTX United States
- Employees
- TOPP N/A
- ANTX N/A
- Industry
- TOPP
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- TOPP
- ANTX Health Care
- Exchange
- TOPP NYSE
- ANTX Nasdaq
- Market Cap
- TOPP 26.6M
- ANTX 33.2M
- IPO Year
- TOPP 2025
- ANTX 2022
- Fundamental
- Price
- TOPP $1.66
- ANTX $1.07
- Analyst Decision
- TOPP
- ANTX Buy
- Analyst Count
- TOPP 0
- ANTX 2
- Target Price
- TOPP N/A
- ANTX $2.00
- AVG Volume (30 Days)
- TOPP 7.6K
- ANTX 287.0K
- Earning Date
- TOPP 08-11-2025
- ANTX 08-12-2025
- Dividend Yield
- TOPP N/A
- ANTX N/A
- EPS Growth
- TOPP N/A
- ANTX N/A
- EPS
- TOPP N/A
- ANTX N/A
- Revenue
- TOPP $16,117,227.00
- ANTX N/A
- Revenue This Year
- TOPP N/A
- ANTX N/A
- Revenue Next Year
- TOPP N/A
- ANTX N/A
- P/E Ratio
- TOPP N/A
- ANTX N/A
- Revenue Growth
- TOPP 0.44
- ANTX N/A
- 52 Week Low
- TOPP $0.97
- ANTX $0.87
- 52 Week High
- TOPP $4.50
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- ANTX 45.19
- Support Level
- TOPP N/A
- ANTX $1.07
- Resistance Level
- TOPP N/A
- ANTX $1.11
- Average True Range (ATR)
- TOPP 0.00
- ANTX 0.04
- MACD
- TOPP 0.00
- ANTX 0.00
- Stochastic Oscillator
- TOPP 0.00
- ANTX 15.04
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.